These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3020057)

  • 1. The antibody response of seronegative infants to inactivated poliovirus vaccine of enhanced potency.
    Simoes EA; John TJ
    J Biol Stand; 1986 Apr; 14(2):127-31. PubMed ID: 3020057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new combined inactivated DPT-polio vaccine.
    Drucker J; Soula G; Diallo O; Fabre P
    Dev Biol Stand; 1986; 65():145-51. PubMed ID: 3030861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents.
    Bégué PC; Grimprel EM; Giovannangeli MD; Abitbol VI
    Pediatr Infect Dis J; 1998 Sep; 17(9):804-9. PubMed ID: 9779766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine.
    Robertson SE; Traverso HP; Drucker JA; Rovira EZ; Fabre-Teste B; Sow A; N'Diaye M; Sy MT; Diouf F
    Lancet; 1988 Apr; 1(8591):897-9. PubMed ID: 2895828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
    Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to measles vaccine with DTPP.
    John TJ; Selvakumar R; Balrai V; Simoes EA
    Am J Dis Child; 1987 Jan; 141(1):14. PubMed ID: 3491536
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody response of infants to two doses of inactivated poliovirus vaccine of enhanced potency.
    Simoes EA; Padmini B; Steinhoff MC; Jadhav M; John TJ
    Am J Dis Child; 1985 Oct; 139(10):977-80. PubMed ID: 2994463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants.
    Lang J; Duong GH; Nguyen VG; Le TT; Nguyen CV; Kesmedjian V; Plotkin SA
    Lancet; 1997 Jun; 349(9066):1663-5. PubMed ID: 9186385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response of children to measles vaccine mixed with diphtheria-pertussis-tetanus or diphtheria-pertussis-tetanus-poliomyelitis vaccine.
    Simoes EA; Balraj V; Selvakumar R; John TJ
    Am J Dis Child; 1988 Mar; 142(3):309-11. PubMed ID: 3257842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV).
    Knuf M; Vetter V; Celzo F; Ramakrishnan G; Van Der Meeren O; Jacquet JM
    Hum Vaccin; 2010 Jul; 6(7):554-61. PubMed ID: 20448468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood.
    Eskola J; Käyhty H; Gordon LK; Hovi T; Stenvik M; Rönnberg PR; Kela E; Peltola H
    Pediatr Infect Dis J; 1988 Jul; 7(7):480-4. PubMed ID: 3261414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
    Lagos R; Kotloff K; Hoffenbach A; San Martin O; Abrego P; Ureta AM; Pines E; Blondeau C; Bailleux F; Levine MM
    Pediatr Infect Dis J; 1998 Apr; 17(4):294-304. PubMed ID: 9576383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants.
    Halperin SA; Davies HD; Barreto L; Guasparini R; Meekison W; Humphreys G; Eastwood BJ
    J Pediatr; 1997 Apr; 130(4):525-31. PubMed ID: 9108847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of adjuvant effect of the pertussis component on IPV DTP-polio vaccine in children.
    Cadoz M; Montagnon B; Yvonnet B; Xueref C; Vincent-Falquet JC; Bandet R; Gibelin N
    Dev Biol Stand; 1986; 65():153-8. PubMed ID: 2881819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological evaluation of poliomyelitis oral and inactivated vaccines in an urban low-income population at Rio de Janeiro, Brazil.
    Schatzmayr HG; Maurice Y; Fujita M; de Fillipis AM
    Vaccine; 1986 Jun; 4(2):111-3. PubMed ID: 3014770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immunogenicity of combined DPT--inactivated injectable polio vaccine (DPT - IPV) and association of DPT and attenuated oral polio vaccine (DPT + OPV) in Pakistani children.
    Qureshi AW; Zulfiqar I; Raza A; Siddiqi N
    J Pak Med Assoc; 1989 Feb; 39(2):31-5. PubMed ID: 2499700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.